Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
12 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Laventair Ellipta (previously Laventair)“
Suchtreffer
Begriffe & Kennungen
Laventair Ellipta (previously Laventair) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 Undesirable effects · 1
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · 7 System Organ Class Adverse reactions Frequency
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · Infections and infestations Urinary tract infection Common Sinusitis Common Nasopharyngitis Common Pharyngitis
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · Summary of the safety profile
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · The frequencies assigned to the adverse reactions identified in the table below include crude incidence rates
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · The frequency of adverse reactions is defined using the following convention: very common (≥1/10); common (≥1/
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · The most frequently reported adverse reaction is nasopharyngitis (9%).
Eintrag öffnenLaventair Ellipta (previously Laventair) · 4.8 · The safety profile of LAVENTAIR ELLIPTA is based on safety experience with umeclidinium/vilanterol and the ind
Eintrag öffnen